These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 30650068
1. Significance of the preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the future remnant liver: a sequential study of regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the whole liver. Tanoue Y, Nanashima A, Yano K, Fujii Y, Hiyoshi M, Imamura N, Hamada T, Ikenoue M, Wada T, Mizutani Y, Hirai T. Nucl Med Commun; 2019 Feb; 40(2):145-152. PubMed ID: 30650068 [Abstract] [Full Text] [Related]
2. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin is correlated with liver functional parameters, but did not predict postoperative morbidity. Yano K, Nanashima A, Fujii Y, Hiyoshi M, Imamura N, Hamada T, Tsuchimochi Y, Wada T, Mizutani Y, Hirai T. Nucl Med Commun; 2017 Aug; 38(8):701-707. PubMed ID: 28644197 [Abstract] [Full Text] [Related]
3. Predictability of 99mTc-Galactosyl Human Serum Albumin Scintigraphy for Posthepatectomy Liver Failure. Kato A, Nakamoto Y, Ishimori T, Seo S, Uemoto S, Togashi K. AJR Am J Roentgenol; 2018 Jan; 210(1):158-165. PubMed ID: 29023153 [Abstract] [Full Text] [Related]
4. Preoperative maximal removal rate of technetium-99m-galactosyl-human serum albumin of the remnant liver is associated with postoperative tumor relapse in hepatitis C virus-related hepatocellular carcinoma. Yano K, Kondo K, Nanashima A, Fujii Y, Imamura N, Hiyoshi M, Hamada T, Tsuchimochi Y, Wada T, Mizutani Y, Hirai T. Nucl Med Commun; 2018 Jan; 39(1):28-34. PubMed ID: 29099413 [Abstract] [Full Text] [Related]
5. Validation set analysis to predict postoperative outcomes by technetium-99m galactosyl serum albumin scintigraphy for hepatectomy. Nanashima A, Hiyoshi M, Imamura N, Yano K, Hamada T, Wada T, Nishimuta M, Shimizu I, Mizutani Y. Nucl Med Commun; 2020 Apr; 41(4):320-326. PubMed ID: 32073550 [Abstract] [Full Text] [Related]
6. Relationship of hepatic functional parameters with changes of functional liver volume using technetium-99m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization: a follow-up report. Nanashima A, Tobinaga S, Abo T, Sumida Y, Araki M, Hayashi H, Sakamoto I, Kudo T, Takeshita H, Hidaka S, Sawai T, Hatano K, Nagayasu T. J Surg Res; 2010 Dec; 164(2):e235-42. PubMed ID: 20869076 [Abstract] [Full Text] [Related]
7. Usefulness of examining hepatic functional volume using technetium-99m galactosyl serum albumin scintigraphy in hepatocellular carcinoma. Nanashima A, Abo T, Kudo T, Sakamoto I, Hayashi H, Murakami G, Takeshita H, Hidaka S, Kido Y, Nagayasu T. Nucl Med Commun; 2013 May; 34(5):478-88. PubMed ID: 23458853 [Abstract] [Full Text] [Related]
8. Preoperative evaluation of hepatic functional reserve following hepatectomy by technetium-99m galactosyl human serum albumin liver scintigraphy and computed tomography. Mitsumori A, Nagaya I, Kimoto S, Akaki S, Togami I, Takeda Y, Joja I, Hiraki Y. Eur J Nucl Med; 1998 Oct; 25(10):1377-82. PubMed ID: 9818276 [Abstract] [Full Text] [Related]
9. Nonsuperiority of technetium-99m-galactosyl human serum albumin scintigraphy over conventional volumetry for assessing the future liver remnant in patients undergoing hepatectomy after portal vein embolization. Yao S, Taura K, Yoh T, Nishio T, Koyama Y, Ogiso S, Okamoto T, Fukumitsu K, Ishii T, Seo S, Hata K, Masui T, Shimizu H, Ishimori T, Hatano E. Surgery; 2023 Feb; 173(2):435-441. PubMed ID: 36372575 [Abstract] [Full Text] [Related]
11. Natural course of the remnant hepatic functional reserve as estimated by technetium-99m-galactosyl human serum albumin scintigraphy after a hepatectomy. Shimizu Y, Aoki T, Kusano T, Matsuda K, Enami Y, Yasuda D, Koizumi T, Niiya T, Murai N, Kato H, Kusano M, Murakami M. J Gastroenterol; 2010 Mar; 45(3):308-16. PubMed ID: 19894018 [Abstract] [Full Text] [Related]
14. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. Kwon AH, Matsui Y, Kaibori M, Ha-Kawa SK. Surgery; 2006 Sep; 140(3):379-86. PubMed ID: 16934599 [Abstract] [Full Text] [Related]
15. Comparison of Tc-99m-GSA scintigraphy with hepatic fibrosis and regeneration in patients with hepatectomy. Iguchi T, Sato S, Kouno Y, Okumura Y, Akaki S, Tsuda T, Kobayashi K, Kanazawa S, Hiraki Y. Ann Nucl Med; 2003 May; 17(3):227-33. PubMed ID: 12846545 [Abstract] [Full Text] [Related]
17. Reducing the incidence of post-hepatectomy hepatic complications by preoperatively applying parameters predictive of liver function. Nanashima A, Tobinaga S, Abo T, Nonaka T, Takeshita H, Hidaka S, Sawai T, Nagayasu T. J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):871-8. PubMed ID: 20734210 [Abstract] [Full Text] [Related]
18. Impaired Value of 99m Tc-GSA Scintigraphy as an Independent Risk Factor for Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma. Nakamura I, Iimuro Y, Hai S, Kondo Y, Hatano E, Fujimoto J. Eur Surg Res; 2018 Nov; 59(1-2):12-22. PubMed ID: 29332090 [Abstract] [Full Text] [Related]
19. Use of technetium 99m diethylenetriamine-pentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Kwon AH, Ha-Kawa SK, Uetsuji S, Kamiyama Y, Tanaka Y. Surgery; 1995 Apr; 117(4):429-34. PubMed ID: 7716725 [Abstract] [Full Text] [Related]